case_images: PMC8645548_01
case_images: PMC8645548_02
case_images: PMC8645548_03
case_images: PMC8645548_04
case_images: PMC8645548_05
case_images: Evolution of the PANSS negative subscale scores during cariprazine treatment.
case_images: fpsyt-12-786171-g0001.jpg
case_images: PMC8645548_05_fpsyt-12-786171-g0001.jpg
case_images: F1
case_images: After 12 weeks of cariprazine 6 mg/day, the positive subscale of PANSS showed a relatively stable level, but the negative subscale mean score decreased with 22% (Figure 1).
case_images: Evolution of the PANSS total scores during cariprazine treatment.
case_images: fpsyt-12-786171-g0002.jpg
case_images: PMC8645548_05_fpsyt-12-786171-g0002.jpg
case_images: F2
case_images: The overall PANSS mean score decreased by 19.5% (Figure 2), the CGI-S mean scores improved by 15.4% (Figure 3), while the mean GAF scores increased by 17%.
case_images: Evolution of the CGI-S scores during cariprazine treatment.
case_images: fpsyt-12-786171-g0003.jpg
case_images: PMC8645548_05_fpsyt-12-786171-g0003.jpg
case_images: F3
case_images: The overall PANSS mean score decreased by 19.5% (Figure 2), the CGI-S mean scores improved by 15.4% (Figure 3), while the mean GAF scores increased by 17%.